Skip to content
Screener

Tectonic Therapeutics TECX Total Liabilities

Total Liabilities at other companies

ALN
Alnylam PharmaceuticalsALNY
$4.2B-2.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
$180.02M+378%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$34.34M+48.0%
Regenxbio logo
RegenxbioRGNX
$314.85M-14.3%
Opko Health logo
Opko HealthOPK
$645.29M-4.6%
Celcuity logo
CelcuityCELC
$356.64M+171%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$639.46M+54.6%
Enterprise value$407.46M+219%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212016
Line itemMarch 31, 2026December 31, 2025
Total current liabilities12,9589,666
Finance lease liability, non-current1743
Operating lease liability, non-current3,185
Total liabilities16,1609,709
Commitments and contingencies (Note 10)
Stockholders’ Equity:
Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 18,830,436 and 18,738,249 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively22
Additional paid-in capital478,393474,160

Item 1. Financial Statements.

FAQ

What is Tectonic Therapeutics's total liabilities?
Tectonic Therapeutics (TECX) reported total liabilities of $16.16M in Q1 2026.
How has Tectonic Therapeutics's total liabilities changed year-over-year?
Tectonic Therapeutics's total liabilities increased by 17.2% year-over-year, from $13.79M to $16.16M.
What is the long-term trend for Tectonic Therapeutics's total liabilities?
Over 5 years (2020 to 2025), Tectonic Therapeutics's total liabilities has grown at a -10.5% compound annual growth rate (CAGR), from $16.89M to $9.71M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Tectonic Therapeutics's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude